Results 1 to 10 of about 611,083 (309)

The impacts of vitamin D supplementation on serum levels of thyroid autoantibodies in patients with autoimmune thyroid disease: a meta-analysis [PDF]

PeerJ
Background Although vitamin D (VitD) deficiency had been found with close relationship with autoimmune thyroid disorders (AITD), the findings about the impacts of VitD supplementation on the production of anti-thyroid peroxidase (TPOAb) and anti ...
Dongdong Luo, Bojuan Li, Zhongyan Shan, Weiping Teng, Qigui Liu, Jing Li   +5 more
doaj   +3 more sources

Autoimmune thyroid disease in infertility and assisted reproductive technology: A review. [PDF]

Porto Biomed J
Pires MI, Póvoa AM, Silva-Soares S.
europepmc   +2 more sources

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review

Frontiers in Oncology, 2022
Classical Hodgkin lymphoma (cHL) is the most common type of HL that occurs mainly in people aged between 15–30 and over 55 years. Although its general prognosis is favorable, 10%–30% of patients with cHL will ultimately develop relapsed or refractory ...
Yujie Zhang, Yujie Zhang, Zhichao Xing, Zhichao Xing, Li Mi, Li Mi, Zhihui Li, Zhihui Li, Jingqiang Zhu, Jingqiang Zhu, Tao Wei, Tao Wei, Wenshuang Wu, Wenshuang Wu   +13 more
doaj   +1 more source

A Mathematical Model to Assess the Effect of Residual Positive Lymph Nodes on the Survival of Patients With Papillary Thyroid Microcarcinoma

Frontiers in Oncology, 2022
BackgroundActive surveillance (AS) has been considered the first-line management for patients with clinical low-risk papillary thyroid microcarcinoma (PTMC) who often have lymph node micrometastasis (m-LNM) when diagnosed.
Wen Liu, Xuejing Yan, Zhizhong Dong, Yanjun Su, Yunhai Ma, Jianming Zhang, Chang Diao, Jun Qian, Tao Ran, Ruochuan Cheng   +9 more
doaj   +1 more source

The landscape of TIGIT target and clinical application in diseases

MedComm – Oncology, 2022
Immune checkpoint blockade has dramatically altered the concept of cancer therapeutics over the past few years. Beyond the existing classical pathways, novel immune checkpoints, such as T‐cell immunoglobulin and immunoreceptor tyrosine‐based inhibitory ...
Shu Rui, Xiangyu Kong, Jiaye Liu, Liying Wang, Xiaofei Wang, Xiuhe Zou, Xun Zheng, Feng Ye, Heng Xu, Zhihui Li, Han Luo   +10 more
doaj   +1 more source

The Inflammatory-Immune Axis in Thyroid Disease: A Mendelian Randomization Study. [PDF]

Int J Endocrinol
Pan T, Fang Z, Hui T, Wu X, Hu X, You J, Liu C.   +6 more
europepmc   +3 more sources

Diagnosis and treatment of medullary thyroid carcinoma-an update [PDF]

Waike lilun yu shijian, 2022
Medullary thyroid carcinoma (MTC) arising from the parafollicular cell (C cell) of the thyroid gland, is an aggressive neuroendocrine tumor and a special rare thyroid malignancy. Calcitonin and carcinoembryonic antigen are still commonly used markers now,
CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben
doaj   +1 more source

Customised 3D-Printed Surgical Guide for Breast-Conserving Surgery after Neoadjuvant Chemotherapy and Its Clinical Application

Bioengineering, 2023
For patients eligible to undergo breast-conserving surgery (BCS) after neoadjuvant chemotherapy, accurate preoperative localisation of tumours is vital to ensure adequate tumour resection that can reduce recurrence probability effectively.
Jie Luo, Feng Chen, Hong Cao, Wei Zhu, Jian Deng, Dan Li, Wei Li, Junjie Deng, Yangyan Zhong, Haigang Feng, Yilin Li, Xiongmeiyu Gong, Jutao Zeng, Jiaren Chen   +13 more
doaj   +1 more source

A Prospective Study of Vitamin D Supplement in Thyroidectomy Patients Based on Relative Decline of Parathyroid Hormone

Frontiers in Pharmacology, 2021
Background: In postthyroidectomy patients, hypocalcemia is the most common complication to prolong hospital stay and decrease patients’ satisfaction.
Qing Hao, Yun Qin, Wanjun Zhao, Lingyun Zhang, Han Luo   +4 more
doaj   +1 more source

Autoimmune Thyroid Disease and Sjögren Disease: Organ-Specific Disease Triggered by Systemic Autoimmunity? [PDF]

Medicina (Kaunas)
Dogru A, Gur Hatip F.
europepmc   +2 more sources